The mislocalization of DR4 and DR5 has been observed in other cell types, including CD4+ T cells (27) and cells of cervical neoplasia (28), melanoma (29), and non-small cell lung cancer (NSCLC) (30, 31). This evidence concerns the gene TNFRSF10B and melanoma.